After administration of Adriamycin, bleomycin, vincristine (ABV) as palliative chemotherapy in advanced AIDS-related Kaposi's sarcoma (AIDS.KS) patients with low Karnosfsky performance scores, the authors attempted to estimate the overall biological cost/benefit relating to the disease. The authors analyzed data from 20 consecutive AIDS patients with advanced Kaposi's sarcoma presenting skin and visceral involvement treated with ABV every 3 weeks. An increased rate of infections, HIV and ABV-related side effects was observed. The performance amelioration (about 30%) was not significantly correlated with AIDS.KS clinical remission. CD4 count at baseline (p < 0.05), ABV therapy duration (p < 0.001), the achieved AIDS.KS clinical amelioration score (p < 0.01) and the improved Karnofsky score (p < 0.001) were significant predictors of life expectancy which was unrelated to the rate of side effects. The authors conclude that ABV palliative chemotherapy can assist in protracting life expectancy and improving the Karnofsky score.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1179/joc.1996.8.5.403 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Could Probiotics and Postbiotics Function as "Silver Bullet" in the Post-COVID-19 Era?
Probiotics Antimicrob Proteins
December 2021
Department of General and Applied Microbiology, Faculty of Biology, Sofia University St. Kliment Ohridski, 8 Dragan Tzankov Blvd, 1164, Sofia, Bulgaria.
We are currently experiencing the realities of the most severe pandemic within living memory, with major impacts on the health and economic well-being of our planet. The scientific community has demonstrated an unprecedented mobilization capability, with the rapid development of vaccines and drugs targeting the protection of human life and palliative measures for infected individuals. However, are we adequately prepared for ongoing defense against COVID-19 and its variants in the post-pandemic world? Moreover, are we equipped to provide a satisfactory quality of life for individuals who are recovering from COVID-19 disease? What are the possibilities for the acceleration of the recovery process? Here, we give special consideration to the potential and already-demonstrated role of probiotics and traditional medical approaches to the management of current and potential future encounters with our major virus adversaries.
View Article and Find Full Text PDFUse of Paclitaxel to Successfully Treat Children, Adolescents, and Young Adults with Kaposi Sarcoma in Southwestern Tanzania.
Children (Basel)
April 2021
Department of Pediatrics, Baylor College of Medicine Children's Foundation-Tanzania, Mbeya 53107, Tanzania.
Treating Kaposi sarcoma (KS) in children, adolescents, and young adults (AYA) remains a challenge in low- and middle-income countries (LMIC) where chemotherapy options and availability are limited. We describe a retrospective cohort review of pediatric patients with KS treated with paclitaxel in Mbeya, Tanzania, between 1 March 2011 and 31 December 2019. Paclitaxel was given to patients who had KS relapse, a contraindication to bleomycin, vincristine, and doxorubicin (ABV), special circumstances in which a clinician determined that paclitaxel was preferable to ABV, or experienced treatment failure, defined as persistent KS symptoms at the completion of treatment.
View Article and Find Full Text PDFPhysician-assisted death: A Canada-wide survey of ALS health care providers.
Neurology
September 2016
From Sunnybrook Health Sciences Centre (A.A., H.P., A.I., W.K., N.P., A.T., L.Z.), University of Toronto, Canada; Universidade Federal de São Paulo (A.A.), Brazil; Critical Care and Palliative Care (J.D.), University Health Network, Toronto; Clinic of Neuromuscular & Neurogenetic Diseases (N.D.), CHU de Québec, Faculty of Medicine, Laval University; Department of Clinical Neurosciences (L.K.), Hotchkiss Brain Institute, University of Calgary; Dalhousie University Faculty of Medicine (C.O.), Stan Cassidy Centre for Rehabilitation; Department of Clinical Neurological Sciences (C.S.), Schulich School of Medicine and Dentistry, University of Western Ontario, Canada; and Division of Rheumatology (A.B.V.-S.), Internal Medicine Department, Universidade do Estado do Rio de Janeiro, Brazil.
Objective: To survey amyotrophic lateral sclerosis (ALS) health care providers to determine attitudes regarding physician-assisted death (PAD) after the Supreme Court of Canada (SCC) invalidated the Criminal Code provisions that prohibit PAD in February 2015.
Methods: We conducted a Canada-wide survey of physicians and allied health professionals (AHP) involved in the care of patients with ALS on their opinions regarding (1) the SCC ruling, (2) their willingness to participate in PAD, and (3) the PAD implementation process for patients with ALS.
Results: We received 231 responses from ALS health care providers representing all 15 academic ALS centers in Canada, with an overall response rate for invited participants of 74%.
Context: Pancreatic cancer is one of the most aggressive malignant diseases in which the survival rate has not improved in the past 40 years.
Case Report: A fifty-one-year-old male patient with inoperable metastatic pancreatic cancer and low response to chemotherapy with gemcitabine as single therapy underwent palliative high intensity focused ultrasound (HIFU) ablation. Continuing chemotherapy with folinic acid, oxaliplatin and 5-fluorouracil (FOLFOX) was made.
[Our medium-term results with aortic balloon valvuloplasty and factors affecting development of aortic regurgitation].
Anadolu Kardiyol Derg
June 2011
Dr. Siyami Ersek Göğüs Kalp ve Damar Cerrahisi Eğitim ve Araştırma Hastanesi, Pediyatrik Kardiyoloji Kliniği, İstanbul, Türkiye.
Objective: The objective of this study was to assess medium-term results of aortic balloon valvuloplasty (ABV) in congenital aortic stenosis and to determine factors affecting development of aortic regurgitation (AR).
Methods: Between September 2003 and January 2010, 114 ABV procedures performed on 97 patients analyzed retrospectively. Patients were evaluated in terms of transvalvular gradients before and after procedure, development of new aortic insufficiency or increase in the current insufficiency and factors affecting the procedural success and development of aortic insufficiency.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!